Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O4MI
|
|||
Former ID |
DNC002280
|
|||
Drug Name |
ISIS 138648
|
|||
Drug Type |
Antisense drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Company |
Isis Pharmaceuticals
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Helicase-moi messenger RNA (DICER1 mRNA) | Target Info | . | [1] |
KEGG Pathway | MicroRNAs in cancer | |||
Pathway Interaction Database | Validated transcriptional targets of TAp63 isoforms | |||
WikiPathways | mRNA Processing | |||
Hypoxia-mediated EMT and Stemness | ||||
RNA interference | ||||
miRNA Biogenesis | ||||
Regulatory RNA pathways |
References | Top | |||
---|---|---|---|---|
REF 1 | US patent application no. 7,427,470, Antisense modulation of helicase-moi expression. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.